Literature DB >> 11224625

Expression of the adhesion molecules Mac-1 and L-selectin on neutrophils in acute pancreatitis is protease- and complement-dependent.

W Hartwig1, R E Jimenez, C Fernandez-del Castillo, A Kelliher, R Jones, A L Warshaw.   

Abstract

OBJECTIVE: To examine the effect of pancreatic proteases on the expression of the adhesion molecules Mac-1 and l-selectin on neutrophils, and the role of complement activation in this process. SUMMARY BACKGROUND DATA: Sequestration of neutrophils in the pancreatic and pulmonary microvasculature characterizes acute pancreatitis.
METHODS: Serum was collected from inbred rats after induction of necrotizing pancreatitis; trypsinogen activation peptide was measured to quantify trypsin activation. Normal rat serum was also collected and subjected to limited trypsin digestion with and without the addition of complement inhibitor. Both groups of sera were incubated in vitro with healthy leukocytes. Expression of Mac-1 and L-selectin on neutrophils was measured quantitatively by flow cytometry. To assess the consequences of these events in vivo, trypsinated serum with or without complement inhibition or control serum was infused intravenous into rats. Soybean trypsin inhibitor was added to serum before injections to block residual trypsin activity. Pancreatic and pulmonary injury was quantitated by histology, measurement of edema, and myeloperoxidase activity.
RESULTS: Mac-1 expression on neutrophils incubated with pancreatitis serum was increased compared with controls, whereas L-selectin was decreased. Neutrophils incubated with trypsinated serum also showed upregulation of Mac-1 and downregulation of L-selectin, particularly with trypsin at 10(-4) mol/L. Addition of soluble complement receptor 1 abrogated both Mac-1 upregulation and L-selectin downregulation. Lungs of animals injected with trypsinated serum showed increased edema and myeloperoxidase activity, which were reduced by soluble complement receptor 1.
CONCLUSIONS: Trypsin-generated complement activation participates in the upregulation of Mac-1 and shedding of L-selectin on neutrophils in acute pancreatitis. Protease or complement inhibition may be effective in preventing leukocyte migration and subsequent local and remote organ injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11224625      PMCID: PMC1421253          DOI: 10.1097/00000658-200103000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  34 in total

1.  Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors.

Authors:  T K Kishimoto; M A Jutila; E L Berg; E C Butcher
Journal:  Science       Date:  1989-09-15       Impact factor: 47.728

2.  Activation of the complement cascade by trypsin.

Authors:  L Roxvall; A Bengtson; L Sennerby; M Heideman
Journal:  Biol Chem Hoppe Seyler       Date:  1991-04

3.  Neutrophil-dependent, oxygen-radical mediated lung injury associated with acute pancreatitis.

Authors:  K S Guice; K T Oldham; M G Caty; K J Johnson; P A Ward
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

4.  A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo.

Authors:  K E Arfors; C Lundberg; L Lindbom; K Lundberg; P G Beatty; J M Harlan
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

5.  Complement (C5)-derived chemotactic activity in serum from patients with pancreatitis.

Authors:  H D Perez; J K Horn; R Ong; I M Goldstein
Journal:  J Lab Clin Med       Date:  1983-01

6.  A better model of acute pancreatitis for evaluating therapy.

Authors:  J Schmidt; D W Rattner; K Lewandrowski; C C Compton; U Mandavilli; W T Knoefel; A L Warshaw
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

7.  Trypsinogen-activation peptides in experimental rat pancreatitis: prognostic implications and histopathologic correlates.

Authors:  J Schmidt; C Fernández-del Castillo; D W Rattner; K Lewandrowski; C C Compton; A L Warshaw
Journal:  Gastroenterology       Date:  1992-09       Impact factor: 22.682

8.  Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury.

Authors:  M S Mulligan; C G Yeh; A R Rudolph; P A Ward
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

9.  Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.

Authors:  H F Weisman; T Bartow; M K Leppo; H C Marsh; G R Carson; M F Concino; M P Boyle; K H Roux; M L Weisfeldt; D T Fearon
Journal:  Science       Date:  1990-07-13       Impact factor: 47.728

10.  Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis.

Authors:  A M Gudgeon; D I Heath; P Hurley; A Jehanli; G Patel; C Wilson; A Shenkin; B M Austen; C W Imrie; J Hermon-Taylor
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

View more
  8 in total

1.  Immunomodulation in surgical practice.

Authors:  R Andersson; B Andersson; E Andersson; G Eckerwall; M Nordén; B Tingstedt
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 2.  Immune-modulating therapy in acute pancreatitis: fact or fiction.

Authors:  Karolina Akinosoglou; Charalambos Gogos
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

3.  Neutrophil engagement and septic challenge in acute experimental pancreatitis in rats.

Authors:  Stanisław Hać; Marek Dobosz; Jan-J Kaczor; Robert Rzepko; Ewa Aleksandrowicz-Wrona; Zdzisław Wajda; Zbigniew Sledziński; Jacek Krajewski
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

4.  Suppression of complement activation by recombinant Crry inhibits experimental autoimmune anterior uveitis (EAAU).

Authors:  Balasubramanian Manickam; Purushottam Jha; Natalie J Hepburn; B Paul Morgan; Claire L Harris; Puran S Bora; Nalini S Bora
Journal:  Mol Immunol       Date:  2010-09-16       Impact factor: 4.407

5.  Time course of lung injury in rat acute pancreatitis.

Authors:  Denis R Morel; Jean-Louis Frossard; Banu Cikirikcioglu; Maxime Tapponnier; Catherine M Pastor
Journal:  Intensive Care Med       Date:  2006-07-15       Impact factor: 17.440

6.  Therapeutic efficacy of high-dose vitamin C on acute pancreatitis and its potential mechanisms.

Authors:  Wei-Dong Du; Zu-Rong Yuan; Jian Sun; Jian-Xiong Tang; Ai-Qun Cheng; Da-Ming Shen; Chun-Jin Huang; Xiao-Hua Song; Xiao-Feng Yu; Song-Bai Zheng
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

Review 7.  Treatment of acute pancreatitis: focus on medical care.

Authors:  Roland Andersson; Anna Swärd; Bobby Tingstedt; Daniel Akerberg
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 8.  Complement in Pancreatic Disease-Perpetrator or Savior?

Authors:  Lucas Bettac; Stephanie Denk; Thomas Seufferlein; Markus Huber-Lang
Journal:  Front Immunol       Date:  2017-01-17       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.